Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

January
17
2017

SRT-100™: The Doctor’s Choice for Treatment of Non-Melanoma Basal Cell Cancer

Giving a skin cancer diagnosis to a patient is never easy. The word “cancer” is a scary word for any patient to hear. Sadly, one in five Americans will develop skin cancer over the course…

January
03
2017

Sensus Healthcare to Participate in Annual JP Morgan Healthcare Conference Week on January 9th – 11th in San Francisco

BOCA RATON, Fla., Jan. 3, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions such as keloids with superficial radiation…

December
20
2016

Sensus Healthcare CEO Shares A Look Into Skin Cancer Treatment

Sensus Healthcare Inc (NASDAQ: SRTS) (NASDAQ: SRTSU) is micro-cap manufacturer of superficial radiation therapy (SRT) devices for the treatment of skin cancer and keloids, which went public on the Nasdaq exchange in June. Benzinga recently…

December
16
2016

Do You Have a Keloid Scar?

If you have a scar that doesn’t seem to be fading, or even appears to be growing in size, it is important to determine whether that scar is a keloid or not. There are two…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy